{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:58:48Z","timestamp":1793249928879,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s13346-022-01130-9","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T15:24:06Z","timestamp":1645716246000},"page":"959-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination"],"prefix":"10.1007","volume":"12","author":[{"given":"James L.","family":"Goodson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"issue":"6497","key":"1130_CR1","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1126\/science.aba9411","volume":"368","author":"A D\u00fcx","year":"2020","unstructured":"D\u00fcx A, Lequime S, Patrono LV, Vrancken B, Boral S, Gogarten JF, et al. Measles virus and rinderpest virus divergence dated to the sixth century BCE. Science (New York, NY). 2020;368(6497):1367\u201370.","journal-title":"Science (New York, NY)"},{"key":"1130_CR2","unstructured":"Cliff. Measles: an historical geography of a major human viral disease from global expansion to local retreat, 1840\u20131990."},{"key":"1130_CR3","unstructured":"Diamond J. Guns, germs, and steel: the fates of human societies."},{"issue":"2","key":"1130_CR4","doi-asserted-by":"publisher","first-page":"16049","DOI":"10.1038\/nrdp.2016.49","volume":"14","author":"PA Rota","year":"2016","unstructured":"Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles Nat Rev Dis Primers. 2016;14(2):16049.","journal-title":"Measles Nat Rev Dis Primers"},{"issue":"2","key":"1130_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3181\/00379727-86-21073","volume":"86","author":"JF Enders","year":"1954","unstructured":"Enders JF. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med. 1954;86(2):277\u201386.","journal-title":"Proc Soc Exp Biol Med"},{"key":"1130_CR6","first-page":"301","volume":"86","author":"World Health Organization (WHO)","year":"2011","unstructured":"World Health Organization (WHO). Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86:301\u201316.","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"1130_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/infdis\/137.6.847","volume":"137","author":"WA Orenstein","year":"1978","unstructured":"Orenstein WA, Halsey NA, Hayden GF, Eddins DL, Conrad JL, Witte JJ, et al. From the Center for Disease Control: current status of measles in the United States, 1973\u20131977. J Infect Dis. 1978;137(6):847\u201353.","journal-title":"J Infect Dis"},{"key":"1130_CR8","first-page":"579","volume-title":"Vaccines","author":"PM Strebel","year":"2018","unstructured":"Strebel PM, Papania MJ, Gasta\u00f1aduy PA, Goodson JL. Measles Vaccines. In: Plotkin S, Orenstein W, Offit P, Edwards KM, editors. Vaccines. 7th ed. Philadelphia, PA: Elisevier; 2018. p. 579\u2013618.","edition":"7"},{"issue":"Suppl 4","key":"1130_CR9","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.1093\/infdis\/jiaa793","volume":"224","author":"PA Gasta\u00f1aduy","year":"2021","unstructured":"Gasta\u00f1aduy PA, Goodson JL, Panagiotakopoulos L, Rota PA, Orenstein WA, Patel M. Measles in the 21st century: progress toward achieving and sustaining elimination. J Infect Dis. 2021;224(Suppl 4):S420\u20138.","journal-title":"J Infect Dis"},{"key":"1130_CR10","doi-asserted-by":"crossref","unstructured":"Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000\u201319: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 2021.","DOI":"10.1016\/S2352-4642(21)00311-4"},{"issue":"Suppl 1","key":"1130_CR11","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/infdis\/jir100","volume":"204","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Proceedings of the global technical consultation to assess the feasibility of measles eradication, 28\u201330 July 2010. J Infect Dis. 2011;204(Suppl 1):S4-13.","journal-title":"J Infect Dis"},{"key":"1130_CR12","doi-asserted-by":"publisher","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","volume":"29","author":"DA Henderson","year":"2011","unstructured":"Henderson DA. The eradication of smallpox \u2013 an overview of the past, present, and future. Vaccine. 2011;29:D7\u20139.","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"1130_CR13","doi-asserted-by":"publisher","first-page":"D74","DOI":"10.1016\/j.vaccine.2012.01.080","volume":"29","author":"J-M Okwo Bele","year":"2011","unstructured":"Okwo Bele J-M, Cherian T. The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine. 2011;29(Suppl 4):D74\u20139.","journal-title":"Vaccine"},{"issue":"43","key":"1130_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.15585\/mmwr.mm7043a1","volume":"70","author":"P Muhoza","year":"2021","unstructured":"Muhoza P, Danovaro-Holliday MC, Diallo MS, Murphy P, Sodha SV, Requejo JH, et al. Routine vaccination coverage \u2013\u00a0worldwide, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(43):1495\u2013500.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1130_CR15","doi-asserted-by":"publisher","first-page":"e1000405","DOI":"10.1371\/journal.pmed.1000405","volume":"8","author":"JG Breman","year":"2011","unstructured":"Breman JG, de Quadros CA, Dowdle WR, Foege WH, Henderson DA, John TJ, et al. The role of research in viral disease eradication and elimination programs: lessons for malaria eradication. PLoS Med. 2011;8(1):e1000405.","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"1130_CR16","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/infdis\/jiu181","volume":"210","author":"PD Rutter","year":"2014","unstructured":"Rutter PD, Donaldson LJ. Oversight role of the independent monitoring board of the global polio eradication initiative. J Infect Dis. 2014;210(Suppl 1):S16-22.","journal-title":"J Infect Dis"},{"issue":"33","key":"1130_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.15585\/mmwr.mm6533a5","volume":"65","author":"S Bahl","year":"2016","unstructured":"Bahl S, Verma H, Bhatnagar P, Haldar P, Satapathy A, Kumar KN, et al. Fractional-dose inactivated poliovirus vaccine immunization campaign \u2013 Telangana State, India, June 2016. MMWR Morb Mortal Wkly Rep. 2016;65(33):859\u201363.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1130_CR18","doi-asserted-by":"publisher","first-page":"15585","DOI":"10.1038\/ncomms15585","volume":"8","author":"S Takahashi","year":"2017","unstructured":"Takahashi S, Metcalf CJE, Ferrari MJ, Tatem AJ, Lessler J. The geography of measles vaccination in the African Great Lakes region. Nat Commun. 2017;8:15585.","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"1130_CR19","doi-asserted-by":"publisher","first-page":"S540","DOI":"10.1093\/infdis\/jiu345","volume":"210","author":"S Cochi","year":"2014","unstructured":"Cochi S, Freeman A, Guirguis S, Jafari H, Aylward B. Global polio eradication initiative: lessons learned and legacy. J Infect Dis. 2014;210(Suppl 1):S540\u20136.","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"1130_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jir111","volume":"204","author":"PM Strebel","year":"2011","unstructured":"Strebel PM, Cochi SL, Hoekstra E, Rota PA, Featherstone D, Bellini WJ, et al. A world without measles. J Infect Dis. 2011;204(Suppl 1):S1\u20133.","journal-title":"J Infect Dis"},{"key":"1130_CR21","unstructured":"The Measles and Rubella Initiative. http:\/\/www.measlesrubellainitiative.org\/. (Accessed 15 Jan\u00a02022). The Measles & Rubella Initiative, 2001."},{"key":"1130_CR22","unstructured":"World Health Organization. Global Vaccine Action Plan 2011\u20132020. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/strategies\/global-vaccine-action-plan. (Accessed 15 Jan 2022). Geneva, Switzerland: World Health Organization, 2012."},{"issue":"45","key":"1130_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.15585\/mmwr.mm6945a6","volume":"69","author":"MK Patel","year":"2020","unstructured":"Patel MK, Goodson JL, Alexander JP Jr, Kretsinger K, Sodha SV, Steulet C, et al. Progress Toward Regional Measles Elimination - Worldwide, 2000\u20132019. MMWR Morb Mortal Wkly Rep. 2020;69(45):1700\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1130_CR24","unstructured":"World Health Organization. Immunization Agenda 2030 (IA2030). https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/strategies\/ia2030. (Accessed 15 Jan 2022). Geneva, Switzerland: World Health Organization, 2020."},{"issue":"Suppl 4","key":"1130_CR25","doi-asserted-by":"publisher","first-page":"S452","DOI":"10.1093\/infdis\/jiab284","volume":"224","author":"A Lindstrand","year":"2021","unstructured":"Lindstrand A, Cherian T, Chang-Blanc D, Feikin D, O\u2019Brien KL. The world of immunization: achievements, challenges, and strategic vision for the next decade. J Infect Dis. 2021;224(Suppl 4):S452\u201367.","journal-title":"J Infect Dis"},{"key":"1130_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.11604\/pamj.supp.2020.35.1.21740","volume":"35","author":"JL Goodson","year":"2020","unstructured":"Goodson JL. Recent setbacks in measles elimination: the importance of investing in innovations for immunizations. Pan Afr Med J. 2020;35:15.","journal-title":"Pan Afr Med J"},{"issue":"42","key":"1130_CR27","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.15585\/mmwr.mm6642a6","volume":"66","author":"A Dabbagh","year":"2017","unstructured":"Dabbagh A, Patel M, Dumolard L, Gacic Dobo M, Mulders M, Okwo Bele J-M, et al. Progress toward regional measles elimination - worldwide, 2000\u20132016. MMWR Morb Mortal Wkly Rep. 2017;66(42):1148\u201353.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"45","key":"1130_CR28","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.15585\/mmwr.mm7045a1","volume":"70","author":"MG Dixon","year":"2021","unstructured":"Dixon MG, Ferrari M, Antoni S, Li X, Portnoy A, Lambert B, et al. Progress toward regional measles elimination - worldwide, 2000\u20132020. MMWR Morb Mortal Wkly Rep. 2021;70(45):1563\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1130_CR29","unstructured":"World Health Organization. Global measles and rubella strategic plan 2012\u20132020. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44855\/9789241503396_eng.pdf;sequence=1. (Accessed 15 Jan 2022). Geneva, Switzerland: World Health Organization, 2012."},{"key":"1130_CR30","unstructured":"WHO. Measles and rubella strategic framework: 2021\u20132030. https:\/\/www.who.int\/publications\/i\/item\/measles-and-rubella-strategic-framework-2021-2030. (Accessed 15 Jan\u00a02022). Geneva, Switzerland: World Health Organization, 2020."},{"issue":"38","key":"1130_CR31","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1016\/j.vaccine.2019.02.058","volume":"37","author":"JL Kriss","year":"2019","unstructured":"Kriss JL, Grant GB, Moss WJ, Durrheim DN, Shefer A, Rota PA, et al. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey. Vaccine. 2019;37(38):5745\u201353.","journal-title":"Vaccine"},{"issue":"38","key":"1130_CR32","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1016\/j.vaccine.2019.01.081","volume":"37","author":"GB Grant","year":"2019","unstructured":"Grant GB, Masresha BG, Moss WJ, Mulders MN, Rota PA, Omer SB, et al. Accelerating measles and rubella elimination through research and innovation \u2013 findings from the Measles & Rubella Initiative research prioritization process, 2016. Vaccine. 2019;37(38):5754\u201361.","journal-title":"Vaccine"},{"issue":"1","key":"1130_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2006.07.039","volume":"25","author":"CP Muller","year":"2007","unstructured":"Muller CP, Kremer JR, Best JM, Dourado I, Triki H, Reef S, et al. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005. Vaccine. 2007;25(1):1\u20139.","journal-title":"Vaccine"},{"issue":"32","key":"1130_CR34","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1016\/j.vaccine.2012.04.058","volume":"30","author":"JL Goodson","year":"2012","unstructured":"Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, et al. Research priorities for global measles and rubella control and eradication. Vaccine. 2012;30(32):4709\u201316.","journal-title":"Vaccine"},{"issue":"13","key":"1130_CR35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.vaccine.2015.11.038","volume":"34","author":"AQ Ford","year":"2016","unstructured":"Ford AQ, Touchette N, Hall BF, Hwang A, Hombach J. Global vaccine and immunization research forum: opportunities and challenges in vaccine discovery, development, and delivery. Vaccine. 2016;34(13):1489\u201395.","journal-title":"Vaccine"},{"key":"1130_CR36","unstructured":"United Nations. UN News: Global perspective human stories. UN agencies shocked and saddened by vaccination deaths in Syria. https:\/\/news.un.org\/en\/story\/2014\/09\/477882-un-agencies-shocked-and-saddened-vaccination-deaths-syria. (accessed 15 Jan 2022). 2014."},{"issue":"3","key":"1130_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/biol.1997.0103","volume":"25","author":"FT Cutts","year":"1997","unstructured":"Cutts FT, Clements CJ, Bennett JV. Alternative routes of measles immunization: a review. Biologicals. 1997;25(3):323\u201338.","journal-title":"Biologicals"},{"issue":"16","key":"1130_CR38","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1407417","volume":"372","author":"N Low","year":"2015","unstructured":"Low N, Bavdekar A, Jeyaseelan L, Hirve S, Ramanathan K, Andrews N, et al. A randomized, controlled trial of an aerosolized vaccine against measles. N Engl J Med. 2015;372(16):1519\u201329.","journal-title":"N Engl J Med"},{"issue":"2","key":"1130_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/14760584.2020.1732215","volume":"19","author":"K Badizadegan","year":"2020","unstructured":"Badizadegan K, Goodson JL, Rota PA, Thompson KM. The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization. Expert Rev Vaccines. 2020;19(2):175\u201394.","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"1130_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/trstmh\/trx018","volume":"111","author":"DN Durrheim","year":"2017","unstructured":"Durrheim DN, Goodson JL. Time for an immunisation paradigm shift. Trans R Soc Trop Med Hyg. 2017;111(2):41\u20132.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1130_CR41","unstructured":"The 2nd global vaccine and immunization research forum (GVIRF). An Emerging Vaccine Delivery Technology for Measles and Rubella Elimination. https:\/\/www.who.int\/immunization\/research\/forums_and_initiatives\/4_JGoodson_emerging_vaccine_delivery_technology_gvirf16.pdf. (Accessed 15 Jan 2022). Johannesburg, South Africa, 2016a."},{"key":"1130_CR42","unstructured":"The 2nd global vaccine and immunization research forum (GVIRF). New Technologies to Support Measles Elimination. https:\/\/www.who.int\/immunization\/research\/forums_and_initiatives\/gvirf\/Plenary5_Measles.pdf?ua=1. (Accessed 15 Jan 2022). Johannesburg, South Africa, 2016."},{"key":"1130_CR43","doi-asserted-by":"crossref","unstructured":"Jeong SY, Park JH, Lee YS, Kim YS, Park JY, Kim SY. The current status of clinical research involving microneedles: a systematic review. Pharmaceutics. 2020;12(11).","DOI":"10.3390\/pharmaceutics12111113"},{"key":"1130_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coviro.2020.05.005","volume":"41","author":"MR Prausnitz","year":"2020","unstructured":"Prausnitz MR, Goodson JL, Rota PA, Orenstein WA. A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination. Curr Opin Virol. 2020;41:68\u201376.","journal-title":"Curr Opin Virol"},{"issue":"48","key":"1130_CR45","first-page":"561","volume":"91","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Meeting of the strategic advisory group of experts on immunization, October 2016 - conclusions and recommendations. Wkly Epidemiol Rec. 2016;91(48):561\u201382.","journal-title":"Wkly Epidemiol Rec"},{"key":"1130_CR46","unstructured":"Gavi, the Vaccine Alliance. Vaccine microarray patches (MAPs): public summary of the VIPS Alliance Action Plan. Alliance Action Plan for microarray patches (gavi.org). (Accessed 15 Jan 2022). 2021."},{"key":"1130_CR47","unstructured":"PATH. The PATH center of excellence for microarray patch technology. PATH, Seattle, WA (2019) https:\/\/www.path.org\/resources\/path-center-excellence-microarray-patch-technology\/. (Accessed 15 Jan 2022). 2019."},{"key":"1130_CR48","doi-asserted-by":"crossref","unstructured":"Giersing BK, Kahn A-L, Jarrahian C, Mvundura M, Rodriguez C, Okayasu H, et al. Challenges of vaccine presentation and delivery: how can we design vaccines to have optimal programmatic impact?. Vaccine. 2017;35(49, Part A):6793\u20137.","DOI":"10.1016\/j.vaccine.2017.04.063"},{"issue":"37","key":"1130_CR49","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1016\/j.vaccine.2015.02.074","volume":"33","author":"C Edens","year":"2015","unstructured":"Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR. A microneedle patch containing measles vaccine is immunogenic in non-human primates. Vaccine. 2015;33(37):4712\u20138.","journal-title":"Vaccine"},{"issue":"10095","key":"1130_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","volume":"390","author":"NG Rouphael","year":"2017","unstructured":"Rouphael NG, Paine M, Mosley R, Henry S, McAllister DV, Kalluri H, Pewin W, TIV-MNP 2015 Study Group, et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017;390(10095):649\u201358.","journal-title":"Lancet"},{"key":"1130_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.02.040","volume":"128","author":"J Arya","year":"2017","unstructured":"Arya J, Henry S, Kalluri H, McAllister D, Pewin W, Prausnitz M. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 2017;128:1\u20137.","journal-title":"Biomaterials"},{"issue":"32","key":"1130_CR52","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1016\/j.vaccine.2019.03.035","volume":"37","author":"N Peyraud","year":"2019","unstructured":"Peyraud N, Zehrung D, Jarrahian C, Frivold C, Orubu T, Giersing B. Potential use of microarray patches for vaccine delivery in low- and middle- income countries. Vaccine. 2019;37(32):4427\u201334.","journal-title":"Vaccine"},{"issue":"26","key":"1130_CR53","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1016\/j.vaccine.2018.05.053","volume":"36","author":"GJP Fernando","year":"2018","unstructured":"Fernando GJP, Hickling J, Jayashi Flores CM, Griffin P, Anderson CD, Skinner SR, et al. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch\u2122). Vaccine. 2018;36(26):3779\u201388.","journal-title":"Vaccine"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-022-01130-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-022-01130-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-022-01130-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:08:36Z","timestamp":1744182516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-022-01130-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s13346-022-01130-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"assertion":[{"value":"7 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}